- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01664026
Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors
January 30, 2019 updated by: Arnaldo Angelino, Clínica Bazterrica
A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support
To evaluate the effect of a 6-month web-based lifestyle modification program with and without telephone counseling versus usual care in obese patients with cardiovascular risk factors on:
- Weight Loss
- Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.
- Physical activity and eating habits
- Quality of life
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Buenos Aires, Argentina
- Clinica Bazterrica
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female 25-70 years of age
- Obese (BMI ≥ 30 kg/m2 and <40 kg/m2)
- At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i) Hypertension defined by a history of hypertension, treatment of hypertension or BP values >140/90 mmHg in two consecutive office visits ii) High cholesterol defined by an LDL-C ≥130 mg/dL and/or HDL-C <40 mg/dL and triglycerides ≥150 mg/dL iii) Type 2 Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting glucose ≥126 mg/dL in two consecutive office visits
- Participant must be willing and able to provide written informed consent
- Participant must be willing and able to comply with study related procedures
- Participant must have access to Internet and e-mail
Exclusion Criteria:
- Stage 1 or 2 on Patient Activation Measures tool
- Weight change of more than 5 kg during the 3 months preceding the screening visit
- History of bariatric surgery
- Fasting Plasma Glucose at screening > 250 mg/dL (> 13.9 mmol/L)
- Hemoglobin A1c at screening >8.5%
- Treatment of type 2 diabetes with insulin (except for history of intermittent acute use, no more than 2 weeks usage in previous 6 months)
- Uncontrolled or inadequately controlled hypertension at the time of screening with blood pressure >160/100 mmHg
- Secondary hypertension
- Changes in lipid, blood pressure or diabetes modifying agents including introduction, change in dose or cessation in the 3 months prior to Screening Visit
- Personal history of coronary heart disease, congestive heart failure, serious arrhythmias and stroke
- Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or other major systemic disease making implementation of the protocol or interpretation of the study results difficult.
- Presence of any condition (medical, psychological, social, or geographical), actual or anticipated, that in the opinion of the Investigator would restrict or limit the patient's successful participation for the duration of the study
- Presence of history of cancer within the past five years with the exception of adequately treated localized basal cell skin cancer or in situ uterine cervical cancer
- Use of systemic glucocorticoids (excluding topical application or inhaled forms) for one week or more within 3 months prior to the time of screening
- Use of any investigational agent (drug, biologic, device) within 3 months prior to screening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Subjects assigned to the usual care group will receive general lifestyle recommendations as per their country standards of care.
|
|
|
Experimental: Web
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.
|
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.
|
|
Experimental: Web+
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.
|
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in body weight from randomization to 6 months
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in waist circumference
Time Frame: 6 months
|
6 months
|
|
Changes in blood pressure
Time Frame: 6 months
|
6 months
|
|
Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)
Time Frame: 6 months
|
6 months
|
|
Changes in glycemic parameters (glucose and hemoglobin A1c)
Time Frame: 6 months
|
6 months
|
|
Changes in C-reactive protein
Time Frame: 6 months
|
6 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in lifestyle behaviors (physical activity and eating habits)
Time Frame: 6 months
|
6 months
|
|
Changes in quality of life
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Andres Digenio, MD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Anticipated)
August 1, 2013
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
August 9, 2012
First Submitted That Met QC Criteria
August 10, 2012
First Posted (Estimate)
August 14, 2012
Study Record Updates
Last Update Posted (Actual)
February 1, 2019
Last Update Submitted That Met QC Criteria
January 30, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- PWeb123
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Web-based lifestyle modification
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; Geisinger Clinic; Pennsylvania Department of HealthCompleted
-
Norwegian University of Science and TechnologyHarvard Medical School (HMS and HSDM); University of Oslo; St. Olavs Hospital; Helse...CompletedPre-Eclampsia | Gestational DiabetesNorway
-
Aysenur KARAKUSCompletedPremenstrual SyndromeTurkey (Türkiye)
-
Asan Medical CenterNot yet recruitingHypertension | Chronic Disease | Hyperlipidemias | Lifestyle Risk Reduction
-
University Health Network, TorontoCanadian Stroke NetworkCompleted
-
UnitedHealth GroupComcast Corporation; Dr. Ron AckermannCompleted
-
Clinical Hospital Centre ZagrebCroatian Institute of Public HealthRecruitingObesity | OverweightCroatia
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of OuluOulu University Hospital; Oulu Deaconess Institute Foundation srCompletedObesity | Physical Activity | Weight Loss | Healthy Obesity, MetabolicallyFinland
-
Diakonie Kliniken ZschadraßCharite University, Berlin, Germany; Chemnitz University of TechnologyCompleted